FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2334103835> ?p ?o ?g. }

• W2334103835 endingPage "43" @default.
• W2334103835 startingPage "34" @default.
• W2334103835 abstract "Experiments were designed to (1) compare the effects of iodinated contrast media (CM) on a rat model of arterial thrombosis, (2) evaluate which element of the ioxaglate solution supports its antithrombotic activity, and (3) investigate the interaction of ionic and non-ionic CM with the antiplatelet agent clopidogrel.Carotid thrombosis was induced in rats by extravascular application of a filter paper soaked in FeCl3 (35% vol/wt), proximal to an ultrasonic flow probe. (1) The antithrombotic potential of low-osmolar ionic (ioxaglate Na/meglumine) or nonionic contrast media (iohexol and iodixanol) (all 1600 mg iodine/kg, IV) was assessed by measuring the time to occlusion (TTO) of the carotid artery and the thrombus weight (TW). (2) Isotonic saline and iso-osmolar (280 mOsm/kg) and hyperosmolar (560 mOsm/kg) solutions of meglumine hydrochloride, meglumine ioxaglate (560 mOsm/kg), sodium ioxaglate (600 mOsm/kg) and sodium and meglumine ioxaglate (commercial solution) were tested under similar conditions. (3) Interaction with clopidogrel was tested by injecting lower dose of CM (960 mg iodine/kg) 2 hours after clopidogrel (2 mg/kg per os).(1) Ioxaglate prolonged TTO when compared with saline (30.0 +/- 1.1 minute vs. 19.6 +/- 2.4 minutes, P< 0.001), whereas iohexol had no effect (21.3 +/- 1.3 minutes). Ioxaglate's effect was associated with a reduction in TW with ioxaglate versus saline (2.6 +/- 0.4 mg and 4.7 +/- 0.7 mg, respectively, P< 0.05) whereas TW remained unchanged in the iohexol group (4.2 +/- 0.4 mg). The nonionic dimer iodixanol induced a direct vasoconstrictor effect on the carotid artery and was consequently excluded from the study. (2) Neither iso-osmolar nor hyperosmolar solutions of meglumine had any effect on TTO whereas both sodium and meglumine salts of ioxaglic acid prolonged TTO, suggesting that the antithrombotic effect of ioxaglate is mediated by the ioxaglic acid moiety alone as neither meglumine, osmolality or sodium played a significant role. (3) A synergistic effect on TTO was found when ioxaglate was associated with clopidogrel whereas no such effect was observed with iohexol.These data show a greater in vivo antithrombotic potential for the ionic contrast medium ioxaglate than for the non-ionic contrast medium iohexol and, for the first time, a synergistic effect between a contrast medium and a platelet antiaggregant drug in vivo." @default.
• W2334103835 created "2016-06-24" @default.
• W2334103835 creator A5015289923 @default.
• W2334103835 creator A5016040044 @default.
• W2334103835 creator A5023624385 @default.
• W2334103835 creator A5034484376 @default.
• W2334103835 date "2003-01-01" @default.
• W2334103835 modified "2023-10-17" @default.
• W2334103835 title "In Vivo Comparative Antithrombotic Effects of Ioxaglate and Iohexol and Interaction With the Platelet Antiaggregant Clopidogrel" @default.
• W2334103835 cites W1415139109 @default.
• W2334103835 cites W153571733 @default.
• W2334103835 cites W1620904680 @default.
• W2334103835 cites W1965552892 @default.
• W2334103835 cites W1976361153 @default.
• W2334103835 cites W1977057072 @default.
• W2334103835 cites W1980027150 @default.
• W2334103835 cites W1990616956 @default.
• W2334103835 cites W1995138820 @default.
• W2334103835 cites W1996122182 @default.
• W2334103835 cites W2000312990 @default.
• W2334103835 cites W2003024087 @default.
• W2334103835 cites W2035961834 @default.
• W2334103835 cites W2039619935 @default.
• W2334103835 cites W2055805671 @default.
• W2334103835 cites W2057293477 @default.
• W2334103835 cites W2060554222 @default.
• W2334103835 cites W2065340893 @default.
• W2334103835 cites W2066714129 @default.
• W2334103835 cites W2075100930 @default.
• W2334103835 cites W2076751649 @default.
• W2334103835 cites W2078333592 @default.
• W2334103835 cites W2081074624 @default.
• W2334103835 cites W2084673482 @default.
• W2334103835 cites W2084825893 @default.
• W2334103835 cites W2113389412 @default.
• W2334103835 cites W2114694439 @default.
• W2334103835 cites W2152327732 @default.
• W2334103835 cites W2165826531 @default.
• W2334103835 cites W2170504653 @default.
• W2334103835 cites W2186143373 @default.
• W2334103835 cites W2325475878 @default.
• W2334103835 cites W2334700473 @default.
• W2334103835 cites W2400498105 @default.
• W2334103835 cites W2415279722 @default.
• W2334103835 cites W2416425504 @default.
• W2334103835 cites W4230884173 @default.
• W2334103835 cites W4376848313 @default.
• W2334103835 cites W2058993252 @default.
• W2334103835 doi "https://doi.org/10.1097/00004424-200301000-00005" @default.
• W2334103835 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12496519" @default.
• W2334103835 hasPublicationYear "2003" @default.
• W2334103835 type Work @default.
• W2334103835 sameAs 2334103835 @default.
• W2334103835 citedByCount "15" @default.
• W2334103835 countsByYear W23341038352014 @default.
• W2334103835 countsByYear W23341038352015 @default.
• W2334103835 countsByYear W23341038352019 @default.
• W2334103835 countsByYear W23341038352021 @default.
• W2334103835 crossrefType "journal-article" @default.
• W2334103835 hasAuthorship W2334103835A5015289923 @default.
• W2334103835 hasAuthorship W2334103835A5016040044 @default.
• W2334103835 hasAuthorship W2334103835A5023624385 @default.
• W2334103835 hasAuthorship W2334103835A5034484376 @default.
• W2334103835 hasConcept C126322002 @default.
• W2334103835 hasConcept C126838900 @default.
• W2334103835 hasConcept C159641895 @default.
• W2334103835 hasConcept C185592680 @default.
• W2334103835 hasConcept C2777015399 @default.
• W2334103835 hasConcept C2777397205 @default.
• W2334103835 hasConcept C2777628954 @default.
• W2334103835 hasConcept C2777849778 @default.
• W2334103835 hasConcept C2779093167 @default.
• W2334103835 hasConcept C2779216453 @default.
• W2334103835 hasConcept C2779786684 @default.
• W2334103835 hasConcept C2780929046 @default.
• W2334103835 hasConcept C2993802102 @default.
• W2334103835 hasConcept C42219234 @default.
• W2334103835 hasConcept C71924100 @default.
• W2334103835 hasConcept C89560881 @default.
• W2334103835 hasConcept C98274493 @default.
• W2334103835 hasConceptScore W2334103835C126322002 @default.
• W2334103835 hasConceptScore W2334103835C126838900 @default.
• W2334103835 hasConceptScore W2334103835C159641895 @default.
• W2334103835 hasConceptScore W2334103835C185592680 @default.
• W2334103835 hasConceptScore W2334103835C2777015399 @default.
• W2334103835 hasConceptScore W2334103835C2777397205 @default.
• W2334103835 hasConceptScore W2334103835C2777628954 @default.
• W2334103835 hasConceptScore W2334103835C2777849778 @default.
• W2334103835 hasConceptScore W2334103835C2779093167 @default.
• W2334103835 hasConceptScore W2334103835C2779216453 @default.
• W2334103835 hasConceptScore W2334103835C2779786684 @default.
• W2334103835 hasConceptScore W2334103835C2780929046 @default.
• W2334103835 hasConceptScore W2334103835C2993802102 @default.
• W2334103835 hasConceptScore W2334103835C42219234 @default.
• W2334103835 hasConceptScore W2334103835C71924100 @default.
• W2334103835 hasConceptScore W2334103835C89560881 @default.
• W2334103835 hasConceptScore W2334103835C98274493 @default.
• W2334103835 hasIssue "1" @default.

• next